Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TLTFF THERALASE TECHNOLOGIES INC

0.192
-0.001-0.52%
Close 09/29 16:00 ET
High
0.192
Open
0.189
Turnover
12.36K
Low
0.181
Pre Close
0.193
Volume
65.92K
Market Cap
41.44M
P/E(TTM)
Loss
52wk High
0.380
Shares
215.50M
P/E(Static)
Loss
52wk Low
0.137
Float Cap
41.44M
Bid/Ask %
0.00%
Historical High
0.380
Shs Float
215.50M
Volume Ratio
1.90
Historical Low
0.137
Dividend TTM
--
Div Yield TTM
--
P/B
21.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
6.07%
Avg Price
0.187
Lot Size
1
Float Cap
41.44M
Bid/Ask %
0.00%
Historical High
0.380
Shs Float
215.50M
Volume Ratio
1.90
Historical Low
0.137
Dividend TTM
--
P/B
21.37
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
6.07%
Avg Price
0.187
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.
CEO: Dr. Arkady Mandel, M.D.,PhD
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...